Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA.... حسب Emir Matpan (21655811)

"…Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. …"

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

A slight negative trend in the relationship between U-Cd levels and BMD in both 2019 and 2022, as evident from the slightly downward-sloping regression lines in both years. However... حسب Aroon La-up (14095691)

الموضوعات:

Significant condition. حسب Junxia Zhou (14381598)

الموضوعات:

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

Brain regions with significantly decreased activations for the Raven task are shown in blue. حسب Morteza Fattahi (15892028)

The level of miRNA 221 in the myocardium of MIRI mice was decreased. حسب Hongyu Li (1332669)

الموضوعات:

Results of significance for regression factors. حسب Junxia Zhou (14381598)

الموضوعات:

Utilization of anticoagulants at eight hospitals from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Inpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Indications for warfarin prescription in outpatients and inpatients in 2023. حسب Wei Luo (80175)

الموضوعات:

Outpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

DDC for four anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

The expenditure on anticoagulants in the period of 2019-2023(million CNY). حسب Wei Luo (80175)

الموضوعات:

RT-qPCR Primer. حسب Dequan Wang (6007007)

الموضوعات:

CCND1 is a target gene of miR-1247-3p. حسب Dequan Wang (6007007)

الموضوعات:

miR-1247-3p was downregulated in CRC resistant cells. حسب Dequan Wang (6007007)

الموضوعات:

miR-1247-3p plasmid. حسب Dequan Wang (6007007)

الموضوعات:

RNA-sequencing data screening for miR-1247-3p target genes. حسب Dequan Wang (6007007)

الموضوعات: